Published in Lung on March 03, 2015
Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib. Drug Des Devel Ther (2015) 0.79
Physical Activity and Exertional Desaturation Are Associated with Mortality in Idiopathic Pulmonary Fibrosis. J Clin Med (2016) 0.75
Original Research: ACE2 activator associated with physical exercise potentiates the reduction of pulmonary fibrosis. Exp Biol Med (Maywood) (2016) 0.75
ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med (2002) 31.79
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 22.39
Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl (1993) 20.55
American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med (2000) 12.71
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med (2014) 10.62
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med (2014) 9.40
Statistics notes: Analysing controlled trials with baseline and follow up measurements. BMJ (2001) 8.98
ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med (2003) 8.83
General considerations for lung function testing. Eur Respir J (2005) 7.99
Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J (2005) 7.58
Standardisation of the measurement of lung volumes. Eur Respir J (2005) 7.48
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet (2011) 5.94
American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med (2006) 5.65
A note on competing risks in survival data analysis. Br J Cancer (2004) 5.60
Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest (2007) 5.01
An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med (2013) 4.49
Time to event (survival) data. BMJ (1998) 4.29
Evaluation of clinical methods for rating dyspnea. Chest (1988) 4.12
Survival probabilities (the Kaplan-Meier method). BMJ (1998) 3.98
Recommendations on the use of exercise testing in clinical practice. Eur Respir J (2007) 3.15
Statistics corner: A guide to appropriate use of correlation coefficient in medical research. Malawi Med J (2012) 2.59
Idiopathic pulmonary fibrosis. Orphanet J Rare Dis (2008) 2.34
The SF-36 and SGRQ: validity and first look at minimum important differences in IPF. Respir Med (2009) 2.18
Sample size for beginners. BMJ (1993) 1.82
Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax (2005) 1.64
The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference. Thorax (2009) 1.46
Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology (2008) 1.32
Age and gender responses to strength training and detraining. Med Sci Sports Exerc (2000) 1.19
Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax (2008) 1.18
Cardiorespiratory and metabolic characteristics of detraining in humans. Med Sci Sports Exerc (2001) 1.09
Detraining: loss of training-induced physiological and performance adaptations. Part II: Long term insufficient training stimulus. Sports Med (2000) 1.06
State of the art: how to set up a pulmonary rehabilitation program. Respirology (2010) 1.02
Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases. Respiration (2009) 1.00
The Medical Research Council dyspnea scale in the estimation of disease severity in idiopathic pulmonary fibrosis. Respir Med (2004) 0.99
Exercise limitation in interstitial lung disease - mechanisms, significance and therapeutic options. Chron Respir Dis (2010) 0.90
Pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis--a review. Respiration (2013) 0.89
Physical training for interstitial lung disease. Cochrane Database Syst Rev (2008) 0.87
Exercise training-based pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis. Respiration (2014) 0.84
Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort study. Respir Med (2013) 0.83
Cross-sectional and longitudinal construct validity of the Saint George's Respiratory Questionnaire in patients with IPF. Respirology (2008) 0.79
Effect of exercise training and detraining on gas exchange kinetics in patients with chronic obstructive pulmonary disease. Clin Physiol (1997) 0.75
Effect of fissure integrity on lung volume reduction using a polymer sealant in advanced emphysema. Thorax (2012) 1.61
Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int (2009) 1.51
Cardiovascular effects of 3 months of football training in overweight children examined by comprehensive echocardiography: a pilot study. J Sports Sci (2013) 1.45
Large vessel aneurysms in Wegener's granulomatosis. J Vasc Surg (2002) 1.01
Bilateral endoscopic sealant lung volume reduction therapy for advanced emphysema. Chest (2012) 1.01
The association of OSA with insulin resistance, inflammation and metabolic syndrome. Respir Med (2007) 0.99
The value of FDG-PET/CT in assessing single pulmonary nodules in patients at high risk of lung cancer. Eur J Nucl Med Mol Imaging (2009) 0.97
Pulmonary hemorrhage: A novel mode of therapy. Respir Med (2009) 0.96
Flexible bronchoscopic management of benign tracheal stenosis: long term follow-up of 115 patients. J Cardiothorac Surg (2010) 0.94
Two-year follow-up in patients treated with emphysematous lung sealant for advanced emphysema. Chest (2013) 0.87
Safety of Cryo-Transbronchial Biopsy in Diffuse Lung Diseases: Analysis of Three Hundred Cases. Respiration (2015) 0.84
Exercise training-based pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis. Respiration (2014) 0.84
Long-term follow-up of flexible bronchoscopic treatment for bronchial carcinoids with curative intent. Diagn Ther Endosc (2010) 0.84
Propofol safety in bronchoscopy: prospective randomized trial using transcutaneous carbon dioxide tension monitoring. Respiration (2011) 0.83
Excess postexercise oxygen consumption is unaffected by the resistance and aerobic exercise order in an exercise session. J Strength Cond Res (2011) 0.83
Prevalence and impact of coronary artery disease in patients with pulmonary arterial hypertension. Am J Cardiol (2011) 0.81
Associations between sports participation, levels of moderate to vigorous physical activity and cardiorespiratory fitness in childrenand adolescents. J Sports Sci (2013) 0.81
Lung cancer in lung transplant recipients: experience of a tertiary hospital and literature review. Lung Cancer (2011) 0.81
Metallic stents for airway complications after lung transplantation: long-term follow-up. Eur J Cardiothorac Surg (2013) 0.81
Endoscopic laser surgery for subglottic stenosis in Wegener's granulomatosis. Yonsei Med J (2007) 0.80
Radiation exposure and attributed cancer risk following lung transplantation. Clin Transplant (2014) 0.79
Limitations in exercise and functional capacity in long-term postpneumonectomy patients. J Cardiopulm Rehabil Prev (2014) 0.79
Physiological modeling of responses to upper versus lower lobe lung volume reduction in homogeneous emphysema. Front Physiol (2012) 0.77
Physiological Profile and Limitations in Exercise in Idiopathic Pulmonary Fibrosis. J Cardiopulm Rehabil Prev (2016) 0.76
An unusual presentation of malignant melanoma metastatic to the lungs and bronchi. Bilateral ground-glass opacities with a "crazy paving" component. Am J Respir Crit Care Med (2015) 0.76
Interferon gamma-1b for pulmonary fibrosis. N Engl J Med (2004) 0.75
Hemofiltration and peritoneal dialysis in infection-associated acute renal failure. N Engl J Med (2003) 0.75
Giant cell arteritis diagnosed by color duplex ultrasonography. Isr Med Assoc J (2002) 0.75
Lifestyle Behaviors and Clinical Outcomes in Idiopathic Pulmonary Fibrosis. Respiration (2017) 0.75
[Bronchial thermoplasty--a novel method for the treatment of severe asthma]. Harefuah (2014) 0.75
Successful Rituximab Therapy in Steroid-Resistant, Cryptogenic Organizing Pneumonia: A Case Series. Respiration (2015) 0.75
Lytic bone lesion: presenting finding of sarcoidosis. Isr Med Assoc J (2010) 0.75
Metabolic Syndrome And Time Spent In Sedentary Activity Shape Carotid-femoral Pulse Wave Velocity: 814 Board #130 June 1, 2: 00 PM - 3: 30 PM. Med Sci Sports Exerc (2016) 0.75
Physiological Responses and Prognostic Value of Common Exercise Testing Modalities in Idiopathic Pulmonary Fibrosis. J Cardiopulm Rehabil Prev (2018) 0.75
Bronchoscopic Drainage of Lung Abscesses Using a Pigtail Catheter. Respiration (2016) 0.75
Endobronchial brachytherapy provides excellent long-term control of recurrent granulation tissue after tracheal stenosis. Brachytherapy (2012) 0.75
Renal function preservation with the mTOR inhibitor, Everolimus, after lung transplant. Clin Transplant (2014) 0.75
Hippocrates, healing, and healthcare materials. Adv Healthc Mater (2013) 0.75